As of 2025-12-25, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is -346.65. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 1,203.91 mil USD. BLFS's TTM EBITDA according to its financial statements is -3.47 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 14.9x | 13.9x |
| Forward P/E multiples | 12.8x - 18.2x | 16.6x |
| Fair Price | (0.54) - 2.71 | 0.98 |
| Upside | -102.1% - -89.4% | -96.2% |
| Date | EV/EBITDA |
| 2025-12-23 | -346.65 |
| 2025-12-22 | -346.79 |
| 2025-12-19 | -341.24 |
| 2025-12-18 | -344.98 |
| 2025-12-17 | -340.41 |
| 2025-12-16 | -334.86 |
| 2025-12-15 | -335.42 |
| 2025-12-12 | -331.81 |
| 2025-12-11 | -338.61 |
| 2025-12-10 | -337.08 |
| 2025-12-09 | -336.80 |
| 2025-12-08 | -339.58 |
| 2025-12-05 | -346.65 |
| 2025-12-04 | -351.78 |
| 2025-12-03 | -347.34 |
| 2025-12-02 | -345.40 |
| 2025-12-01 | -345.96 |
| 2025-11-28 | -361.07 |
| 2025-11-26 | -363.56 |
| 2025-11-25 | -367.86 |
| 2025-11-24 | -358.99 |
| 2025-11-21 | -361.48 |
| 2025-11-20 | -329.18 |
| 2025-11-19 | -331.68 |
| 2025-11-18 | -326.82 |
| 2025-11-17 | -326.55 |
| 2025-11-14 | -327.38 |
| 2025-11-13 | -342.21 |
| 2025-11-12 | -353.03 |
| 2025-11-11 | -354.69 |
| 2025-11-10 | -358.16 |
| 2025-11-07 | -353.16 |
| 2025-11-06 | -368.28 |
| 2025-11-05 | -375.90 |
| 2025-11-04 | -369.52 |
| 2025-11-03 | -380.06 |
| 2025-10-31 | -380.06 |
| 2025-10-30 | -366.61 |
| 2025-10-29 | -375.49 |
| 2025-10-28 | -381.59 |
| 2025-10-27 | -382.42 |
| 2025-10-24 | -392.82 |
| 2025-10-23 | -391.01 |
| 2025-10-22 | -375.49 |
| 2025-10-21 | -377.43 |
| 2025-10-20 | -379.92 |
| 2025-10-17 | -372.44 |
| 2025-10-16 | -378.12 |
| 2025-10-15 | -392.26 |
| 2025-10-14 | -377.15 |